Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinomaCorrection to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma, Published online: 06 August 2018; doi:10.1038/s41419-018-0880-7Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
Source: Cell death and disease - Category: Internal Medicine Authors: Shuang Wei Zun-yi Zhang Sheng-ling Fu Jun-gang Xie Xian-sheng Liu Yong-jian Xu Jian-ping Zhao Wei-ning Xiong Source Type: research
More News: Adenocarcinoma | Internal Medicine